Comparison of Blood and Urinary Cannabis Profiles Between Road Traffic Injury (RTI) and Other Causes of Death in Thai Postmortem Cases
Article Sidebar
Main Article Content
Abstract
Objective This study aims to compare blood and urinary cannabis profiles between road traffic injury (RTI) and other unnatural causes of death in the Thai population.
Methods A cross-sectional study was conducted of Thai postmortem cases where the individual who died was 15 years old or over. Sex, age, cause of death, manner of death, blood alcohol concentration (BAC), and concomitant drugs found were documented for each case. Blood and urinary concentrations of delta9-tetrahydrocannabinol (THC) and its two metabolites, 11-hydroxy-delta9-tetrahydrocannabinol (11-OH-THC) and 11-nor-9-carboxy-delta9-tetrahydrocannabinol (THC-COOH), were analyzed using gas chromatography tandem mass spectrometry (GC-MS/MS). Statistical analysis was performed using the Mann-Whitney U test and Kruskal-Wallis H test.
Results A total of 80 subjects were included in this study, comprising 43 RTI and 37 non-RTI subjects. All the RTI cases were motorcycle riders. Blood concentrations of THC, 11-OH-THC, and THC-COOH in the RTI group were significantly higher than those in the non-RTI group (p < 0.01). The number of subjects who had recent cannabis exposure in the RTI group was significantly higher than in the non-RTI group (p< 0.05). Furthermore, the blood concentrations of THC, 11-OH-THC, and THC-COOH in subjects who used cannabis without other drugs of abuse or medications were significantly higher than those in subjects who used cannabis with other drugs of abuse or other medications (p < 0.05).
Conclusions Blood THC, 11-OH-THC, and THC-COOH concentrations in RTI cases were significantly higher than in cases with other unnatural causes of death.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Hasin D, Walsh C. Trends over time in adult cannabis use: A review of recent findings. Curr Opin Psychol. 2021;38:80-5.
Kalayasiri R, Boonthae S. Trends of cannabis use and related harms before and after legalization for recreational purpose in a developing country in Asia. BMC Public Health. 2023;23:911. PubMed PMID: 37208663
Angkurawaranon C, Jiraporncharoen W, Likhitsathian S, Thaikla K, Kanato M, Perngparn U, et al. Trends in the use of illicit substances in Thailand: Results from national household surveys. Drug Alcohol Rev. 2018;37:658-63.
Jayuphan J, Assanangkornchai S, Wichaidit W. Cannabis use behaviors and related harms among adults in Thailand by sex assigned at birth and age groups. J Health Sci Med Res. 2024;42:1-15.
Atisook R, Mochadaporn C, Chanthong P, Sriveerachai P, Zinboonyahgoon N. Prevalence and characteristics of medicinal cannabis use among chronic pain patients; A post- legalization study in a tertiary care setting in Thailand. Siriraj Med J. 2024;76:21-30.
Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007;4:1770-804.
Brubacher JR, Chan H, Erdelyi S, Macdonald S, Asbridge M, Mann RE, et al. Cannabis use as a risk factor for causing motor vehicle crashes: a prospective study. Addiction. 2019;114:1616-26.
Lemos NP, San Nicolas AC, Volk JA, Ingle EA, Williams CM. Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers. J Anal Toxicol. 2015;39:588-601.
Rooney B, Gouveia GJ, Isles N, Lawrence L, Brodie T, Grahovac Z, et al. Drugged Drivers Blood Concentrations in England and Wales Prior to the Introduction of Per Se Limits. J Anal Toxicol. 2017;41:140-5.
Scientific Working Group for Forensic Toxicology. Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology. J Anal Toxicol. 2013;37:452-74.
Hartman RL, Brown TL, Milavetz G, Spurgin A, Pierce RS, Gorelick DA, et al. Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend. 2015;154:25-37.
Drummer OH, Gerostamoulos D, Di Rago M, Woodford NW, Morris C, Frederiksen T, et al. Odds of culpability associated with use of impairing drugs in injured drivers in Victoria, Australia. Accid Anal Prev. 2020;135:105389. PubMed PMID: 31812899.
Qian Y, Gurley BJ, Markowitz JS. The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications. J Clin Psychopharmacol. 2019;39:462-71.
Ho JJY, Goh C, Leong CSA, Ng KY, Bakhtiar A. Evaluation of potential drug-drug interactions with medical cannabis. Clin Transl Sci. 2024;17(5):e13812. PubMed PMID: 38720531.
Wu LT, Pilowsky DJ, Schlenger WE. High prevalence of substance use disorders among adolescents who use marijuana and inhalants. Drug Alcohol Depend. 2005;78:23-32.
Zhang S, Wu S, Wu Q, Durkin DW, Marsiglia FF. Adolescent drug use initiation and transition into other drugs: A retrospective longitudinal examination across race/ethnicity. Addict Behav. 2021;113:106679. PubMed PMID: 33032193.
Desrosiers NA, Himes SK, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clin Chem. 2014;60:631-43.
Brenneisen R, Meyer P, Chtioui H, Saugy M, Kamber M. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9- tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes. Anal Bioanal Chem. 2010;396:2493-502.
Goodwin RS, Darwin WD, Chiang CN, Shih M, Li SH, Huestis MA. Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence. J Anal Toxicol. 2008;32:562-9.
